@prefix this: <http://purl.org/np/RAOBgKeDknwaUkV-tJZnH9QdUdIT9hj67pv3NwXTIUHIY> .
@prefix sub: <http://purl.org/np/RAOBgKeDknwaUkV-tJZnH9QdUdIT9hj67pv3NwXTIUHIY#> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix biolink: <https://w3id.org/biolink/vocab/> .
@prefix ns1: <https://w3id.org/np/o/ntemplate/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix npx: <http://purl.org/nanopub/x/> .
sub:Head {
  this: np:hasAssertion sub:assertion ;
    np:hasProvenance sub:provenance ;
    np:hasPublicationInfo sub:pubInfo ;
    a np:Nanopublication .
}
sub:assertion {
  <http://purl.obolibrary.org/obo/HP_0000709> a biolink:Disease .
  sub:association rdf:object <http://purl.obolibrary.org/obo/HP_0000709> ;
    rdf:predicate biolink:treats ;
    rdf:subject <https://identifiers.org/DRUGBANK:DB00363> ;
    a rdf:Statement ;
    rdfs:label "Patients with Parkinson's disease psychosis (PDP) are often treated with an atypical antipsychotic, especially quetiapine or clozapine, but side effects, lack of sufficient efficacy, or both may motivate a switch to pimavanserin, the first medication approved for management of PDP." ;
    biolink:has_population_context sub:context ;
    biolink:provided_by <https://w3id.org/um/NeuroDKG> ;
    biolink:publications <https://pubmed.ncbi.nlm.nih.gov/30588905> ;
    biolink:relation <https://w3id.org/um/neurodkg/OffLabelIndication> .
  sub:context a biolink:Cohort ;
    rdfs:label "Adults" ;
    biolink:has_phenotype <http://purl.obolibrary.org/obo/MONDO_0005180> .
  <https://identifiers.org/DRUGBANK:DB00363> a biolink:Drug .
}
sub:provenance {
  sub:assertion prov:generatedAtTime "2021-08-24T20:13:50.640391"^^xsd:dateTime .
}
sub:pubInfo {
  sub:sig npx:hasAlgorithm "RSA" ;
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB" ;
    npx:hasSignature "F6PcR5J56A0r2WUq5Bt+W3zwKdEyn99Proh4djvGxPE1opq7kotapHBV3cKM8icV1RdZoeVBi6V8WateJ2bvZf5W7m4sx9Mz6VcVjS8PPf/sAKZlieYgN3joEdyhGvBdI6wfXA3MhrMmgMexKXYi3EDmzbORXRfgQPQHall1mDs=" ;
    npx:hasSignatureTarget this: .
  this: prov:generatedAtTime "2021-08-24T20:13:50.640391"^^xsd:dateTime ;
    prov:wasAttributedTo <https://orcid.org/0000-0002-7641-6446> ;
    ns1:wasCreatedFromTemplate <http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY> .
}